References
- American Lung Association. Chronic Obstructive Pulmonary Disease. [cited 2009 April 3]; Available from: www.lungusa.org
- National Heart Lung and Blood Institute, Morbidity and Mortality: 2007 Chartbook on Cardiovascular, Lung and Blood Diseases. 2007 [cited 2009 April 3]; Available from: www.nhlbi.nih.gov
- American Association of Respiratory Care (AARC). COPD Resources. [cited 2009 April 3]; Available from: www.aarc.org
- Chronic Obstructive Pulmonary Disease (COPD). Department of Health and Human Services. Centers for Disease Control and Prevention. [cited 2009 April 3]; Available from: www.cdc.gov
- Institute for Clinical Systems Improvement (ICSI). Chronic obstructive pulmonary disease. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI). 2007 [cited 2009 April 3]; Available from: www.clinicaltrials.gov
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Updated 2008). [cited 2009 April 3]; Available from: www.goldcopd.gov
- National Institute for Health and Clinical Excellence (NICE). Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care. 2004 [cited 2009 April 3]; Available from: www.nice.org.uk
- Braman SS. Chronic cough due to chronic bronchitis: ACCP evidence-based clinical practice guidelines. Chest 2006;129(1 Suppl):104-15S
- Qaseem A, Snow V, Shekelle P, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2007;147:633-8
- Finnish Medical Society Duodecim. Chronic obstructive pulmonary disease (COPD). In: EBM Guidelines. Evidence-Based Medicine. [cited 2009 April 3]; Available from: www.clinicaltrials.gov
- Asche CV, Brixner DI, Sonoscenti CS, et al. Assessment of physician prescribing for primary care patients with chronic obstructive pulmonary disease (COPD) in a national electronic medical record (EMR) research database. Chest 2006;130:175S
- Lucas AEM, Smeenk FW, Smeele IJ, et al. Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. Fam Pract 2008;25:86-91
- Wu N, Plauschinat C, Chen S, et al. Inhaled corticosteroid use and prior exacerbations among patients with chronic obstructive pulmonary disorder. Am J Respir Crit Care Med 2010;181:A4485
- Charlson ME, Charlson RE, Peterson JC, et al. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol 2008;61:1234-40
- Bureau of Labor Statistics: Consumer Price Index. January 2008 [cited 2009 April 3]; Available from: www.bls.gov
- Afifi AA, Kotlerman JB, Ettner SL, et al. Methods for improving regression analysis for skewed continuous or counted responses. Annu Rev Public Health 2007;28:95-111
- McCullagh P, Nelder JA. Generalized Linear Models, 2nd edn. London: Chapman and Hall, 1989
- Van Schayck CP, Van Grunsven PM, Dekhuijzen PNR. Do patients with COPD benefit from treatment with inhaled corticosteroids? Eur Respir J 1996;9:1969-72
- Nannini LJ, Cates CJ, Lasserson TJ, et al. Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews (Online) 2007(4):CD006829
- Singh S, Amin AV, Loke YK. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease. Arch Intern Med 2009;169:219-29
- Chanez P, Vignola AM, O'Shaugnessy T, et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med 1997;155:1529-34